This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
MMD Overzicht aandelen
Milestone Medical, Inc. develops, manufactures, commercializes, and markets intra-articular and epidural drug delivery systems in the United States and Europe.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 0/6 |
| Dividenden | 0/6 |
Milestone Medical, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | zł1.58 |
| 52 Week Hoogtepunt | zł2.74 |
| 52 Week Laag | zł1.43 |
| Bèta | 0.83 |
| 11 maand verandering | 0% |
| 3 maanden verandering | n/a |
| 1 Jaar Verandering | -18.97% |
| 33 jaar verandering | -84.20% |
| 5 jaar verandering | -73.67% |
| Verandering sinds IPO | -78.21% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| MMD | PL Medical Equipment | PL Markt | |
|---|---|---|---|
| 7D | 0% | -4.1% | -1.2% |
| 1Y | -19.0% | -5.1% | 3.2% |
Rendement versus industrie: MMD underperformed the Polish Medical Equipment industry which returned -11.8% over the past year.
Rendement versus markt: MMD underperformed the Polish Market which returned 35.1% over the past year.
Prijsvolatiliteit
| MMD volatility | |
|---|---|
| MMD Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 8.5% |
| 10% least volatile stocks in PL Market | 3.1% |
Stabiele aandelenkoers: MMD has not had significant price volatility in the past 3 months.
Volatiliteit in de loop van de tijd: Insufficient data to determine MMD's volatility change over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2011 | 12 | Arjan Haverhals | medicalmilestone.com |
Milestone Medical, Inc. Samenvatting
| MMD fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | zł34.76m |
| Inkomsten(TTM) | -zł13.92m |
| Inkomsten(TTM) | zł29.24k |
1,189x
P/S-verhouding-2.5x
Koers/WinstverhoudingIs MMD overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| MMD resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$7.40k |
| Kosten van inkomsten | US$254.35k |
| Brutowinst | -US$246.95k |
| Overige uitgaven | US$3.28m |
| Inkomsten | -US$3.52m |
Laatst gerapporteerde inkomsten
Sep 30, 2023
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.16 |
| Brutomarge | -3,337.15% |
| Nettowinstmarge | -47,612.84% |
| Schuld/Eigen Vermogen Verhouding | -97.2% |
Hoe presteerde MMD op de lange termijn?
Bekijk historische prestaties en vergelijking